Arkolith/Insider Trading/ANGN/Form 4

Nissenson Allen

DirectorAngion Biomedica Corp. (ANGN) · full profile →Form 4 · filed May 23, 2022
Net Buying
Open-Market Buys
$11K
Open-Market Sells
$0
Net Open-Market Flow
$11K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 20, 2022Buy(P)2K$1.18$2K9K
May 19, 2022Buy(P)7K$1.16$9K7K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001628280-22-015238) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML